The causes and consequences of cancer-associated malnutrition.

[1]  F. Bozzetti.  Nutritional Support in Patients with Cancer , 2015 .

[2]  P. Schein,et al.  Gastrointestinal toxicity of chemotherapeutic agents. , 2006, Seminars in oncology.

[3]  M. Reid.  Response of the ubiquitin-proteasome pathway to changes in muscle activity. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  S. Wigmore,et al.  Systemic inflammation, cachexia and prognosis in patients with cancer , 2005, Current opinion in clinical nutrition and metabolic care.

[5]  Jun Tian,et al.  Nutritional status and quality of life of the gastric cancer patients in Changle County of China. , 2005, World journal of gastroenterology.

[6]  M. Tisdale,et al.  NF-κB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin–proteasome system in skeletal muscle , 2005, British Journal of Cancer.

[7]  J. Chamberlain.  Cachexia in cancer--zeroing in on myosin. , 2004, The New England journal of medicine.

[8]  T. Eisen,et al.  Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? , 2004, British Journal of Cancer.

[9]  Mellar P. Davis,et al.  Appetite and cancer-associated anorexia: a review. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Paula Ravasco,et al.  Cancer: disease and nutrition are key determinants of patients’ quality of life , 2004, Supportive Care in Cancer.

[11]  K. Fearon,et al.  Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids , 2004, British Journal of Cancer.

[12]  M. Mori,et al.  Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen‐independent prostate carcinoma , 2004, Cancer.

[13]  J. Marshall,et al.  The Relationship Between a Urinary Cachectic Factor and Weight Loss in Advanced Cancer Patients , 2004, Cancer investigation.

[14]  S. Hidaka,et al.  Increased serum levels of interleukin-6 in malnourished patients with colorectal cancer. , 2003, Cancer letters.

[15]  J. Rossi,et al.  Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  F. López‐Soriano,et al.  Catabolic mediators as targets for cancer cachexia. , 2003, Drug discovery today.

[17]  D. Walsh,et al.  Evaluation of nutritional status in advanced metastatic cancer , 2003, Supportive Care in Cancer.

[18]  F. López‐Soriano,et al.  Cytokines in the pathogenesis of cancer cachexia , 2003, Current opinion in clinical nutrition and metabolic care.

[19]  R. Cone,et al.  Differential role of melanocortin receptor subtypes in cachexia. , 2003, Endocrinology.

[20]  S. Griffin,et al.  Postoperative taste and smell deficit after upper gastrointestinal cancer surgery—an unreported complication , 2003, Journal of surgical oncology.

[21]  Marinos Elia,et al.  Disease-related Malnutrition: An Evidence-based Approach to Treatment , 2003 .

[22]  J. Epstein,et al.  Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation , 2002, Bone Marrow Transplantation.

[23]  M. Tisdale,et al.  Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo , 2002, British Journal of Cancer.

[24]  R. Koretz.  The Science and Practice of Nutrition Support: A Case-Based Core Curriculum , 2002 .

[25]  C. McArdle,et al.  The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer , 2002, British Journal of Cancer.

[26]  B. Barton,et al.  Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen. , 2001, Cytokine.

[27]  J. Epstein,et al.  Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge , 2001, Supportive Care in Cancer.

[28]  I. Bosaeus,et al.  Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients , 2001, International journal of cancer.

[29]  K. Fearon.  Nutritional support in cancer , 2001 .

[30]  J. Marshall,et al.  Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss , 2001, British Journal of Cancer.

[31]  J. Ross,et al.  Effect of a Fish Oil-Enriched Nutritional Supplement on Metabolic Mediators in Patients With Pancreatic Cancer Cachexia , 2001, Nutrition and cancer.

[32]  M. Tisdale,et al.  Cancer anorexia and cachexia. , 2001, Nutrition.

[33]  G. Gibson,et al.  The influence of nutritional status on complications after operations for lung cancer. , 2001, The Annals of thoracic surgery.

[34]  Patricia M Sheean,et al.  Impact of declines in nutritional status on outcomes in adult patients hospitalized for more than 7 days. , 2000, Journal of the American Dietetic Association.

[35]  A. Körner,et al.  Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. , 2000, Cancer research.

[36]  G. Nitenberg,et al.  Nutritional support of the cancer patient: issues and dilemmas. , 2000, Critical reviews in oncology/hematology.

[37]  K. Fearon,et al.  Disordered Metabolic Response with Cancer and Its Management , 2000, World Journal of Surgery.

[38]  C. Hill,et al.  Prevalence of malnutrition on admission to four hospitals in England. The Malnutrition Prevalence Group. , 2000, Clinical nutrition.

[39]  M. Grant,et al.  Symptoms and their impact on nutrition. , 2000, Seminars in oncology nursing.

[40]  E. Mutlu,et al.  Nutrition in the Care of the Cancer Patient , 2000 .

[41]  R. Negrin,et al.  Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[42]  A. Inui,et al.  Cancer anorexia-cachexia syndrome: are neuropeptides the key? , 1999, Cancer research.

[43]  G. Snow,et al.  The impact of nutritional status on the prognoses of patients with advanced head and neck cancer , 1999, Cancer.

[44]  S. Shott,et al.  Taste changes experienced by patients receiving chemotherapy. , 1999, Oncology nursing forum.

[45]  P. Sjödén,et al.  The Swedish version of the patient-generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers. , 1999, Clinical nutrition.

[46]  D. Osoba,et al.  Quality of life and oral function following radiotherapy for head and neck cancer , 1999, Head & neck.

[47]  M. Tisdale,et al.  Mechanism of muscle protein degradation induced by a cancer cachectic factor. , 1998, British Journal of Cancer.

[48]  C. Plata-salamán,et al.  Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. , 1998, The American journal of physiology.

[49]  J. Sitzia,et al.  Patients' experiences of chemotherapy: side-effects associated with 5-fluorouracil + folinic acid in the treatment of colorectal cancer. , 1998, Journal of clinical nursing.

[50]  N. Tchekmedyian.  Pharmacoeconomics of nutritional support in cancer. , 1998, Seminars in oncology.

[51]  A. Norman,et al.  Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? , 1998, European journal of cancer.

[52]  C. Gogos,et al.  Dietary omega‐3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy , 1998, Cancer.

[53]  M. Gottschlich,et al.  Contemporary Nutrition Support Practice: A Clinical Guide , 1998 .

[54]  J. Sitzia,et al.  Side effects of CHOP in the treatment of non-hodgkin's lymphoma. , 1997, Cancer nursing.

[55]  C. Blanke,et al.  Nursing care strategies for the management of side effects in patients treated for colorectal cancer. , 1997, Seminars in oncology.

[56]  A. Moreno,et al.  Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery. , 1997, Nutrition.

[57]  G. Snow,et al.  Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications , 1997, Head & neck.

[58]  Rodney W. Johnson,et al.  Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1 β in the rat , 1997, Brain Research.

[59]  B. Bistrian,et al.  Mechanisms of host wasting induced by administration of cytokines in rats. , 1997, The American journal of physiology.

[60]  J. Sitzia,et al.  Patients' experiences of chemotherapy: side-effects of carboplatin in the treatment of carcinoma of the ovary. , 1997, European journal of cancer care.

[61]  C. McArdle,et al.  The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. , 1996, British Journal of Cancer.

[62]  A. Laviano,et al.  Nutritional issues in cancer management. , 1996, Nutrition.

[63]  A. Foltz,et al.  Recalled side effects and self-care actions of patients receiving inpatient chemotherapy. , 1996, Oncology nursing forum.

[64]  D. Greenspan.  Xerostomia: diagnosis and management. , 1996, Oncology.

[65]  E. Wouters,et al.  Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  G. Strassmann,et al.  Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy. , 1995, Cytokines and molecular therapy.

[67]  J. Ross,et al.  Acute‐phase protein response and survival duration of patients with pancreatic cancer , 1995, Cancer.

[68]  Ottery Fd.  Supportive nutrition to prevent cachexia and improve quality of life. , 1995 .

[69]  H. Deeg,et al.  Impact of patient weight on non-relapse mortality after marrow transplantation. , 1995, Bone marrow transplantation.

[70]  L. Moldawer,et al.  Cytokine‐mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients , 1995, Journal of surgical oncology.

[71]  J. Blay,et al.  Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. , 1994, Blood.

[72]  L. Moldawer,et al.  Tumor necrosis factor and cachexia: a current perspective. , 1994, Surgical oncology.

[73]  J. Ross,et al.  Cytokines, the Acute‐Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer , 1994, Annals of surgery.

[74]  P. Coyle,et al.  Altered insulin response to glucose in weight-losing cancer patients. , 1994, Anticancer research.

[75]  B. Mealey,et al.  The head and neck radiotherapy patient: Part 1--Oral manifestations of radiation therapy. , 1994, Compendium.

[76]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[77]  Susan Holmes,et al.  Food avoidance in patients undergoing cancer chemotherapy , 1993, Supportive Care in Cancer.

[78]  J. Fanning,et al.  High-dose cisplatin carboplatin chemotherapy in primary advanced epithelial ovarian cancer. , 1993, Gynecologic oncology.

[79]  M. Tisdale,et al.  Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. , 1993, British Journal of Cancer.

[80]  L. Bernstein,et al.  Effect of nutrition status and other factors on length of hospital stay after major gastrointestinal surgery. , 1993, Nutrition.

[81]  D. Heber,et al.  Hormonal and metabolic abnormalities in the malnourished cancer patient: effects on host-tumor interaction. , 1992, JPEN. Journal of parenteral and enteral nutrition.

[82]  L. Moldawer,et al.  The role of cytokines in cancer cachexia. , 1992, JPEN. Journal of parenteral and enteral nutrition.

[83]  J. Blay,et al.  Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. , 1992, Cancer research.

[84]  G. Strassmann,et al.  Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. , 1992, Journal of immunology.

[85]  T. Fahey,et al.  Nutritional support of the cancer patient , 1992, JPEN. Journal of parenteral and enteral nutrition.

[86]  A. M. Lindsey,et al.  Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle. , 1992, Oncology nursing forum.

[87]  H. Langstein,et al.  The Roles of γ-Interferon and Tumor Necrosis Factor α in an Experimental Rat Model of Cancer Cachexia , 1991 .

[88]  I. Ferrier,et al.  Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. , 1990, British Journal of Cancer.

[89]  M. Zeiderman,et al.  The role of objective measurement of skeletal muscle function in the pre-operative patient. , 1989, Clinical nutrition.

[90]  Lesko Lm.  Psychosocial issues in the diagnosis and management of cancer cachexia and anorexia. , 1989 .

[91]  Buss Cl.  Nutritional support of cancer patients. , 1987 .

[92]  D. Debonis,et al.  Influence of nutritional status on the resumption of adequate food intake in patients recovering from colorectal cancer operations. , 1986, The Surgical clinics of North America.

[93]  G. Padilla,et al.  Psychological aspects of nutrition and cancer. , 1986, The Surgical clinics of North America.

[94]  P. McAndrew,et al.  Fat metabolism and cancer. , 1986, The Surgical clinics of North America.

[95]  T. Oei,et al.  Effect of nutrition staging on treatment delays and outcome in stage IV neuroblastoma , 1983, Cancer.

[96]  Schiffman Ss.  Taste and smell in disease (second of two parts). , 1983 .

[97]  S. Schiffman.  Taste and smell in disease. , 1983, The New England journal of medicine.

[98]  R. Storb,et al.  Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.

[99]  H. Douglass,et al.  Is taste related to anorexia in cancer patients? , 1982, The American journal of clinical nutrition.

[100]  Joseph R. Bertino,et al.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.

[101]  W. Dewys.  Anorexia as a general effect of cancer , 1979, Cancer.

[102]  Dewys Wd.  Changes in taste sensation and feeding behaviour in cancer patients: a review. , 1978 .

[103]  J. Carson,et al.  Taste acuity and food attitudes of selected patients with cancer. , 1977, Journal of the American Dietetic Association.

[104]  M. Elia,et al.  Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. , 2006, International journal of oncology.

[105]  P. Ravasco.  Aspects of taste and compliance in patients with cancer. , 2005, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[106]  J. Dickerson,et al.  Malignant disease: nutritional implications of disease and treatment , 2004, Cancer and Metastasis Reviews.

[107]  C. Langer,et al.  Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. , 2001, Nutrition.

[108]  D. Silk,et al.  Artificial nutrition support in clinical practice. , 2001 .

[109]  M. Tisdale.  Wasting in cancer. , 1999, The Journal of nutrition.

[110]  Whitmyer Cc,et al.  Radiotherapy and oral sequelae: preventive and management protocols. , 1997 .

[111]  L. Nail,et al.  A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. , 1994, Cancer practice.

[112]  E. L. Mortensen,et al.  The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. , 1993, Nutrition and cancer.

[113]  G. Opdenakker,et al.  Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. , 1991, European journal of cancer.

[114]  L. Moldawer,et al.  Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. , 1991, Cancer research.

[115]  D. Gandara,et al.  Progress in the control of acute and delayed emesis induced by cisplatin. , 1991, European journal of cancer.

[116]  K. Lundholm,et al.  Elevated energy expenditure in cancer patients with solid tumours. , 1991, European journal of cancer.

[117]  M. Goldstein,et al.  Impact of nutritional status on DRG length of stay. , 1987, JPEN. Journal of parenteral and enteral nutrition.

[118]  J. Fischer,et al.  Correlation of changes in brain indoleamine metabolism with onset of anorexia in rats. , 1982, American journal of surgery.